APA (7th ed.) Citation

Refaat, B., Elzubier, M. E., Aslam, A., Idris, S., & Farrash, W. F. (2026). The GLP‐1 Receptor Agonist Liraglutide Promotes Anticancer Activities in MCF7 Breast and PC‐3 Prostate Cancer Cells by Modulating Glycolysis, Oxidative Stress and Adipokines. Journal of Biochemical & Molecular Toxicology, 40(6), 1. https://doi.org/10.1002/jbt.70913

Chicago Style (17th ed.) Citation

Refaat, Bassem, Mohamed E. Elzubier, Akhmed Aslam, Shakir Idris, and Wesam F. Farrash. "The GLP‐1 Receptor Agonist Liraglutide Promotes Anticancer Activities in MCF7 Breast and PC‐3 Prostate Cancer Cells by Modulating Glycolysis, Oxidative Stress and Adipokines." Journal of Biochemical & Molecular Toxicology 40, no. 6 (2026): 1. https://doi.org/10.1002/jbt.70913.

MLA (9th ed.) Citation

Refaat, Bassem, et al. "The GLP‐1 Receptor Agonist Liraglutide Promotes Anticancer Activities in MCF7 Breast and PC‐3 Prostate Cancer Cells by Modulating Glycolysis, Oxidative Stress and Adipokines." Journal of Biochemical & Molecular Toxicology, vol. 40, no. 6, 2026, p. 1, https://doi.org/10.1002/jbt.70913.